Possibilities of Use MRI-Guided Laser Interstitial Thermal Therapy in Medically Intractable Tremor
PossibiLITT
Possibilities of Use Magnetic Resonance Imaging (MRI)-Guided Laser Interstitial Thermal Therapy (LITT) in Treatment of Medically Intractable Tremor
1 other identifier
interventional
15
1 country
1
Brief Summary
Medically intractable tremors are a common difficult clinical situation. Deep brain stimulation decreases Parkinson's disease tremor and essential tremor, but not all patients are candidates from a diagnostic, medical, or social standpoint, prompting the need for alternative surgical strategies. Less invasive lesional brain surgery (thalamotomy) procedures by radio-surgery or MRI-guided focused ultrasound have emerged and have proven to be effective in these third-line indications. Recently, a new technology has emerged allowing the performance of minimally invasive lesion surgeries by MRI-Guided Laser Interstitial Thermal Therapy (MRIg-LITT). MRIg-LITT has been shown to be effective and safe in management of epilepsies and brain tumors. However, no study has evaluated MRIg-LITT for performing thalamotomy in medically intractable tremor.In a pilot study, the investigators propose to evaluate the effect and safety of unilateral thalamotomy by MRIg-LITT in the management of medically intractable tremor of parkinsonian or essential origin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 24, 2024
CompletedFirst Posted
Study publicly available on registry
January 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedJanuary 29, 2025
September 1, 2024
1.1 years
September 24, 2024
January 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variation of total body weight from baseline
To assess the impact of UF prescription guided by the ECW/TBWat ratio on weight loss, a comparison of TBW (∆TBW) between the two groups will be conducted. The ∆TBW is the difference between the initial TBW at H0 and the TBW at H72.
at 72 hours
Secondary Outcomes (1)
cumulative fluid balance
at 72 hours
Study Arms (1)
Parkinson's disease
EXPERIMENTALPatients 18 years age or older with Parkinson's disease or essential tremor and tremor resistant to medical therapy with a contraindication to deep brain stimulation or refusal deep brain stimulation
Interventions
A laser electrode is implanted surgically in the ventral and inteermediary nucleus of the thalamus (VIM).
Eligibility Criteria
You may qualify if:
- Patients 18 years age or older with Parkinson\'s disease or essential tremor and tremor resistant to medical therapy with a contraindication to deep brain stimulation or refusal deep brain stimulation
You may not qualify if:
- Contraindication to MRI
- Contraindication to general anesthesia
- Patient unable to give their free and informed consent because of cognitive or psychiatric disorders
- Brain anatomical abnormalities not allowing intervention
- Adults protected (guardianship, curators) or deprived of liberty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire, Amienslead
- University Hospital, Rouencollaborator
- University Hospital, Caencollaborator
- Central Hospital Saint Quentincollaborator
Study Sites (1)
CHRU Amiens
Salouël, 80480, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2024
First Posted
January 29, 2025
Study Start
August 1, 2024
Primary Completion
September 1, 2025
Study Completion
April 1, 2026
Last Updated
January 29, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share